Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Allurion stock soars on weight-loss therapy update. Stardust Power breaks ground on Oklahoma lithium refinery. OpenAI ...

Detailed price information for Immunoprecise Antibodies Ltd (IPA-Q) from The Globe and Mail including charting and trades.

These statements relate to, among other things, the anticipated benefits and impact of the AI-driven peptide discovery pipeline, the potential for computationally designed GLP-1 analogs to improve ...

To prevent rapid weight loss, Chadha refrains from incrementing patients’ doses of GLP-1 analogs every 4 weeks, she said. Instead, she increases the dose when patients start to plateau on the ...

Liraglutide is a GLP-1 analog, which is resistant to degradation. Phase III trials have demonstrated that liraglutide effectively controls glucose levels, while reducing bodyweight.

Thanks to this, analogs that function similarly to GLP-1 are used as treatments for patients with type 2 diabetes, who have insufficient insulin secretion. Recently, it has also gained attention ...